Table 1.
Baseline characteristics of the study population based on the primary vaccine dose (n = 540).
| Vaccine type | |||
|---|---|---|---|
| Variables | ChadOx1 (n = 158) | BNT162b2 (n = 138) | AD26.COV2.S (n = 244) |
| Mean age (± SD) years | 36.3 ± 12.8 | 36.4 ± 13.0 | 37.1 ± 13.6 |
| Age group n(%) | |||
|
18–55 years 56–65 years |
147(93.0) 11(7.0) |
125(90.6) 13(9.4) |
218(89.3) 26(10.7) |
| Sex | |||
| Female | 79(50) | 82(59.4) | 161 (66) |
| Male | 79(50) | 56(40.6) | 83(34) |
| Marital status | |||
| Married | 84(53.2) | 72(52.2) | 135(55.3) |
| Unmarried | 74(46.8) | 66(47.8) | 109 (44.7) |
| Educational level | |||
| None | 10 (6.3) | 5(3.6) | 20 (8.2) |
| Primary | 20 (12.7) | 29(21) | 41(16.8) |
| Secondary | 81(51.3) | 67(48.6) | 126(51.6) |
| Tertiary | 47 (29.7) | 37(26.8) | 57(23.4) |
| Occupation | |||
| Employed | 116(73.4) | 107(77.5) | 194 (79.5) |
| Unemployed | 42(26.6) | 31(22.5) | 50(20.5) |
| Average income | |||
| 1–30,000 | 67(42.4) | 62(44.9) | 136(55.7) |
| Above 30,000 | 34(21.5) | 25(18.1) | 46(18.9) |
| Seropositivity baseline | |||
| Negative | 56(35.4) | 57(41.3) | 61(25) |
| Positive | 101(63.9) | 81(58.7) | 183(75) |